This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Tübingen High Altitude Ophthalmology Study (THAO)

This study has been completed.
Information provided by:
University Hospital Tuebingen Identifier:
First received: November 19, 2010
Last updated: December 2, 2010
Last verified: July 2010
Tuebingen High Altitude Ophthalmology Study to investigate the effects of high altitude on retinal structure and function as well as anterior chamber in regard to acute mountain sickness.

Altitude Hypoxia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Tübingen High Altitude Ophthalmology Study (THAO)

Further study details as provided by University Hospital Tuebingen:

Study Completion Date: December 2010

Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
healthy volunteers

Inclusion Criteria:

  • healthy subjects, non-smokers, physical fitness,

Exclusion Criteria:

  • ocular pathologies, ascent above 2000m 2 weeks prior to study and 2 weeks before post-examination
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01245114

Eye Hospital, University of Tübingen
Tübingen, BW, Germany, 72076
Sponsors and Collaborators
University Hospital Tuebingen
Study Director: Florian Gekeler, MD Eye Hospital, University of Tübingen, Germany
Principal Investigator: Gabriel Willmann, MD Eye Hospital, University of Tübingen, Germany
  More Information

Responsible Party: Prof. Florian Gekeler, Eye Hospital, University Hospital Tübingen, Germany Identifier: NCT01245114     History of Changes
Other Study ID Numbers: THAO
Study First Received: November 19, 2010
Last Updated: December 2, 2010 processed this record on August 18, 2017